Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis

BACKGROUND: The standard first-line systemic treatment for patients with non-oncogene addicted advanced nonsquamous non-small cell lung cancer (NSCLC) is immunotherapy with immune checkpoint inhibitors (ICI) and/or chemotherapy (ChT). Therapy after failing ICI +/− ChT remains an open question, and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljubicic, Lidija, Janzic, Urska, Unk, Mojca, Terglav, Ana Sophie, Mohorcic, Katja, Seiwerth, Fran, Bitar, Lela, Badovinac, Sonja, Plestina, Sanja, Korsic, Marta, Kukulj, Suzana, Samarzija, Miroslav, Jakopovic, Marko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476899/
https://www.ncbi.nlm.nih.gov/pubmed/37665737
http://dx.doi.org/10.2478/raon-2023-0040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476899/
https://www.ncbi.nlm.nih.gov/pubmed/37665737
http://dx.doi.org/10.2478/raon-2023-0040

Ejemplares similares